Navigation Links
Findings on Dangerous Parasite, Toxoplasma Gondii Published

Montana State University researchers and their collaborators are gaining widespread attention for discoveries involving// a common parasite that can threaten everyone from babies to AIDS patients.

Their findings about Toxoplasma gondii and toxoplasmosis were published recently in three major scientific journals. Nature published a paper in its advanced online version.

"It's not often you get such a cluster of papers coming out," said Michael White, one of the authors and an MSU professor of veterinary molecular biology. He added that MSU researchers will have another opportunity to explain the studies when they host an international conference on toxoplasmosis at Chico Hot Springs.

Toxoplasmosis is normally associated with medical advice that pregnant women avoid changing cat litter, but it's gaining new attention because of the AIDS epidemic and bioterrorism, the researchers said. Severe toxoplasmosis can cause AIDS patients to go into a deep dementia and become unconscious of their surroundings.

"It's one of the worst syndromes an AIDS patient can die from," said Jay Radke, another of the MSU authors.

Toxoplasmosis is a disease caused by the parasite Toxoplasma gondii. Symptoms usually appear only in people with weakened immune systems, but on rare occasions, healthy people suffer serious eye and central nervous system problems from toxoplasmosis. Their babies can have birth defects. White said toxoplasmosis also may be linked to some cases of schizophrenia and bipolar disease. It can kill livestock and has devastated efforts to restore sea otters near Monterey, Calif. Because it's common, yet complex, toxoplasmosis is a potential weapon for bioterrorists.

People usually acquire toxoplasmosis by eating commercial meat or drinking water that's contaminated with Toxoplasma gondii, White said. They can also pick it up by handling soil or anything that has come in contact with cat feces.
"It's a complex cell just likes ours in terms of metabolism and biochemistry, which makes it a tough nut to crack," White said.

The recently-published studies show that molecular interactions between the parasite and host directly regulate the disease's severity, White said. Genes from the parasite also disrupt signals in the host's immune system and control the establishment of life-long chronic disease.

Genetic crosses produced at MSU were critical in the study that discovered that the parasite dumps a protein into the host to dramatically regulate its immune response, White said. Labs in MSU's Department of Veterinary Molecular Biology and MSU's microarray facility helped establish the role of a second pathogen protein that makes one strain of Toxoplasma especially dangerous.

"Type I strains are extremely important to human medicine as they are disproportionately responsible for inflammation of the brain in AIDS patients and for severe congenital disease that is passed from mother to baby," White said.

MSU led the study that was published in PloS, White said. MSU made major contributions to the Nature and Science papers which were collaborations with Stanford University and Washington University in St. Louis.

The studies give other scientists a model for studying toxoplasmosis or related diseases like malaria and Eimeria, which causes coccidiosis, White added. Eimeria parasites kill chickens and other commercially-raised animals like cattle.

A press release from Washington University said researchers in the future will try to develop more effective treatments against toxoplasmosis by blocking ROP18, the gene largely responsible for making toxoplasmosis so dangerous to humans. The Toxoplasma gondii parasite has approximately 6,000 genes in all. Scientists will also look for other genes that work together with ROP18.


Related medicine news :

1. Latest Findings On The Deadly Disease - SARS
2. New Findings Could Reduce The Extent Of Spinal Cord Injuries
3. New Findings for Repeated Miscarriages
4. How Healthy Are Herbal Products? US Findings.
5. Dispute in Findings about Radiation exposure
6. New Findings on Autism Research
7. Engineering Nutrient-Rich Plants Made For Feasible By New Findings
8. Study Findings Could Help In Developing A Better Drug Delivery System
9. Findings Suggest New Method to Fight Staph Infections
10. Most Suicide Rates Decline, but Findings Are Puzzling
11. Arimidex-Herceptin Combo Therapy For Breast Cancer-Clinical Trial Findings
Post Your Comments:

(Date:11/24/2015)... CA (PRWEB) , ... November 24, 2015 , ... ... sizes, has launched their Black Friday sale a week early, offering 40% off ... to transform the intimate apparel industry through both mobile fit technology and the ...
(Date:11/24/2015)... , ... November 24, 2015 , ... Preparing for the ... – 3:00 p.m. EST, , FDA has long asserted that design ... apply to performing the tests and do not meet the device regulations. , Come ...
(Date:11/24/2015)... ... November 24, 2015 , ... United Benefit Advisors (UBA), ... & Company as its newest Partner Firm. Based in Jefferson City, Missouri, their ... trusted advisor regardless of whether that client is a business, a family, or ...
(Date:11/24/2015)... ... 2015 , ... With Thanksgiving right around the corner, holiday travel season is ... your family and vehicle. , According to the National Highway Traffic Safety Administration, 301 ... sharing the following safety tips from the NHTSA: , ...
(Date:11/24/2015)... ... November 24, 2015 , ... Dr. Rodney E. Willey , has answered a ... Koala Center for Sleep Disorders, provides treatment for snoring and sleep apnea through ... a Koala Center for Sleep Disorders in the US, one of four in the Illinois ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... Nov. 24, 2015  Enova Illumination is pleased to ... Helsinki, Finland to combine their world ... the cutting edge of medical visualization: Enova is the ... the United States and Novocam is the ... provide the world,s most powerful battery-operated LED headlight with ...
(Date:11/24/2015)... Nov. 24, 2015 Abaxis, Inc. (NasdaqGS: ... and consumables for the medical, research, and veterinary markets ... Financial Officer, will present at the 27 th ... 2015 at 11:30 a.m. ET. The conference will be ... New York City . Abaxis, ...
(Date:11/24/2015)...   Mast Therapeutics, Inc. (NYSE MKT: MSTX), ... sealant technology (MAST) platform to develop novel therapies for ... that the Company,s Chief Executive Officer, Brian M. ... th Annual Healthcare Conference on Tuesday, December 1, ... Palace hotel in New York City ...
Breaking Medicine Technology: